What is Thesis?
Thesis operates as the world's first personalized brain supplement brand, addressing the unique cognitive demands of individual users. By utilizing a sophisticated data-driven approach, the company offers customized nootropic blends designed to enhance focus, creativity, energy, and memory without the adverse effects associated with conventional stimulants. The company's product development is supported by a network of neuroscientists from prestigious institutions including Yale, Penn, and MIT, ensuring that their offerings remain at the cutting edge of cognitive science and consumer safety.
How much funding has Thesis raised?
Thesis has raised a total of $8.4M across 1 funding round:
Series A
$8.4M
Series A (2023): $8.4M with participation from Break Trail Ventures, Unilever Ventures, Alive.vc, and REDO Ventures
Key Investors in Thesis
Break Trail Ventures
Break Trail Ventures is an early-stage venture fund that partners with entrepreneurs who prioritize customer needs and address significant challenges in their industries.
Unilever Ventures
Unilever Ventures specializes in investing in high-growth companies to help them achieve brand recognition and scale their operations globally.
REDO Ventures
REDO Ventures partners with exceptional entrepreneurs to build transformational B2C companies, leveraging deep operating experience to foster market leaders.
What's next for Thesis?
With this latest infusion of capital, Thesis is poised to deepen its research capabilities and expand its reach within the competitive wellness market. The strategic focus will likely center on scaling its personalized delivery model and enhancing its digital infrastructure to accommodate a growing user base. As the company matures, the integration of further clinical insights will be critical in maintaining its market leadership and establishing long-term brand equity in the personalized health space. The support from institutional partners provides the necessary runway to navigate the complexities of the consumer health sector while maintaining a commitment to scientific rigor and product efficacy.
See full Thesis company page
